OBJECTIVE: Because survival time varies greatly, it is difficult for dementia patients to meet a key criterion for eligibility for the Medicare hospice benefit: a 6-month survival time.
P < .001. When the palliative care plans were examined, less aggressive care plans resulted in shorter survival times, P < .01. CONCLUSION Our hospice enrollment criteria identified a group with a median survival time of 4 months and a mean survival time of 6.9 months. Using NHO criteria relying on the FAST allows the identification of a subgroup with very high mortality and a short time until death. Although the FAST can identify a subgroup of appropriate candidates for hospice, sole reliance on this measure might decrease access to hospice care for many dementia patients. J Am Geriatr SOC 45:1054-1059,1997.
nd-stage dementia is a significant clinical problem for E which alternative modes of care are needed. Many patients with end stage dementia are ideal candidates for hospice because their prognosis is terminal and aggressive medical treatment is rarely preferred.'-' Palliative care is intended to relieve symptoms, to control pain, and, thereby, to ease death rather than to prolong life. These goals apply to endstage dementia patients, who often die of medical complications of the disease such as aspiration pneumonia. Reports of pilot hospice programs for dementia patients suggest that this approach is feasible3" as well as ethical.'~6-8 In one survey, 90% of family and professional caregivers of dementia patients viewed hospice care as appropriate for the end stages of the disease.' Yet only 13% were aware of hospices that served dementia patients compared with. 87% who were aware of hospice services for cancer patients. This suggests unmet need.
For editorial comment, see p. 1147
Lack of utilization of hospice care in advanced dementia was further documented in our national survey of 1184 hospice programs.' Fewer than 1 % of hospice patients had a primary diagnosis of dementia. A study that examined Medicare beneficiaries in hospice had similar findings; 1.5% of hospice patients had dementia as a primary diagnosis." Among hospice staff from our national survey, 80% viewed difficulties in predicting the survival time of dementia patients as a major problem in their efforts to serve these patients. Eligibility for the Medicare hospice benefit requires a prognosis of death within 6 months. However, survival time in Alzheimer's disease and vascular dementia is highly variable and can range from 2 to 10 years." Recent evidence has confirmed that dementia patients in hospice have a significantly longer survival time than those with other diagnoses, with 35% surviving longer than 6 months." Yet relatively little research has been conducted on the development of empirically based standards for enrolling patients with endstage dementia in hospice, aside from the pioneering studies of Volicer and his colleagues in an institutional h o~p i c e .~, '~ In a study of a home-based hospice, we have developed enrollment criteria that identified a group of dementia patients whose median survival time was 5 months, with a mean of 7 months (Table  The main purpose of this research was to expand the study to institutional hospice settings as well as to replicate our findings with home hospice patients.
A second purpose concerns the analysis of the National Hospice Organization (NHO) guidelines. Since these studies began, NHO guidelines have been developed to assist primary care physicians to identify "patients with nononcological disease who may be appropriate for admission to a hospice program. . . under the MedicareIMedicaid Hospice Benefit."13 Medical guidelines for assessing prognosis were developed for other terminal illnesses in addition to dementia, for example, heart disease and pulmonary disease. It is anticipated that a revised version will include more guidelines for other end-stage conditions. The guidelines are designed not to function as strict admission criteria but to assist physicians in making clinical judgments. With regard to dementia, the NHO guidelines parallel our own but with the addition of a more detailed description of medical complications and the suggestion that Stage Seven C of Functional Assessment Staging may be an appropriate cutoff point for enrollment (Table 2 ).l39l4 Using our experience with the patients in our study, we have examined the implications of these refinements. 
METHODS

Patients
Enrollment criteria developed for the study consisted of advanced dementia and a history of medical complications during the year before enrollment (Table 1) . Patients were eligible for hospice if they were severely demented, with very low mental status, needed assistance in most Activities of Daily Living, and were no longer able to communicate beyond an occasional word or two. Patients were also required to have a recent history of complications typical of end-stage dementia, for example, aspiration pneumonia, which causes swallowing problems. Patients who fit the criteria were enrolled in the following two cohorts: (1) Meridian Hospice between 11/1/90 and 10/31/92 (n = 11) and (2) nine Midwestern hospices between 4/1/93 and 3/31/95 (n = 36). Enrollment stopped 6 months before the end of each 2-year study period in order to allow for a 6-month follow-up period. No information is available about those patients who did not meet the criteria for admission to hospice although anecdotal evidence from hospice staff suggests that there were very few such patients.
Settings
Settings included the following nine Midwestern hospices: Meridian Hospice, Henry Ford Hospice, LaGrange 
Measures
After training in the use of the assessment instruments, hospice nurses collected patient information for the research staff. Because the hospice staffs were not accustomed to assessing the severity of dementia, a range of measures was used both to assist them in making this assessment and to establish baseline levels of disability. The following measures were included.
Cognitive Impairment cognitive impairment.
Functional Impairment Levels
Activities of Daily Living were rated on a 3-point scale (independent, needs assistance, totally dependent) from the Older Adults Resources and Services Instrument For example, with regard to eating, staff were asked to rate whether the patient could eat: (1) Without help (can feed self completely), (2) With some help (needs help cutting, etc.), or was (3) Completely unable to feed self.
Medical Complications Checklist
The Medical Complications Checklist (MCC) consisted of a list of common complications of end-stage dementia and when the problem occurred (current vs within the past year).
Complications included swallowing problems, aspiration pneumonia, malnutrition, dehydration, decubitus ulcers, urinary tract infections, septicemia, seizures, fractures or broken bones, and deep vein thrombosis. The checklist was based on typical complications in advanced dementia according to physicians who responded to our previous survey.2
Survival Time
Survival Time consisted of the number of days between enrollment in the hospice program and the patient's death, or if patients were not deceased, the number of days from enrollment until 10/31/92 for the first cohort and until 3/31/95 for the second cohort.
Additional Measures
Additional Measures were used with the second cohort in order to further characterize factors influencing survival time:
Pwformance Ratings
These were drawn from a study of survival time among cancer patients in hospice: Appetite: 1 = normal to 5 = refuses fluid; Nourishment: 1 = heavy to 5 = extreme cachexia; and Mobility: 1 = normal to 5 = unable to turn in bed."
Level of Deterioration
In the Functional Assessment Staging (FAST), the seven stages of previously dementia described in the Global Deterioration Scale (GDS) are further elaborated, and an ordinal progression is assumed (Appendix ).14, 19 For example, Stage
The Mental Status Quotient" was used to establish Seven is the most severe stage of dementia in the GDS. In the FAST, Stage Seven has been further subdivided to include six additional levels of disease progression in which the following deficits are assumed to occur in sequential order. At Stage Seven A, speech is limited to about six words in the course of a day. Next, at Stage Seven By intelligible vocabulary is limited to a single word in the course of the day. Subsequently, at Stage Seven C, ambulatory ability becomes impaired, and physical assistance is needed to walk. These impairments are followed by the loss of the ability to sit up (7D), to smile (7E), and to hold the head up (7F).
Palliative Care Plan
Hospice staff were asked to characterize the palliative care plan with regard to whether or not medications could be used for acute illnesses.
Data Analysis
Descriptive statistics were used to characterize demographics, diagnosis, and survival time. Initially, univariate analysis was used to identify variables related to survival time (i.e., the correlation between performance ratings of mobility and survival time). Significant univariate relationships were then examined using multiple regression. With regard to NHO guidelines, a one-way ANOVA was used to compare survival times among those whose impairment was characteristic of Stage Seven C of the FAST, those who had not yet reached Stage Seven C, and those who could not be scored (see results for further discussion of this issue). Additionally, the combined effect of the patient's care plan and status on the FAST was examined using a two-factor ANOVA.
RESULTS
Subjects
orty-seven patients were enrolled in hospice care. The majority were women (70%). Their average age was 84 (SD = 9.2). The majority (66%) were white (66%), and the remainder were black. Most had Alzheimer's disease (71 YO). The remainder had vascular disease (9"/), a mixed dementia, usually vascular disease and Alzheimer's disease (6%), Parkinson's disease (6%), or an unspecified dementia (8%). As per the enrollment criteria, all clients were severely impaired in their capacity to perform Activities of Daily Living (ADL) and had medical complications related to their dementia. Eighty-six percent had more than one medical complication. The majority had swallowing problems (72%). Decubitus ulcers also occurred frequently (70%). Aspiration pneumonia was common (55%), as were dehydration (57%), malnutrition (SO%), and urinary tract infections (37%). The patients' cognitive impairments were so severe that most were unable to participate in tests of mental status. The severity of the dementia corresponded to Stage Seven on the Global Deterioration Scale for all but one of the patients, who was in Stage Six E of the FAST.I4
Median Survival Time
Among the 47 patients, median survival time was 4 months, with an average of 6.9 months (SD = 7.3 months); 18 (38%) survived longer than 6 months. The 37 deceased patients from both cohorts had a mean survival time of 4.5 months (SD = 6.5 months). The average survival time for the 10 patients (21%) who were still alive was 15.7 months (SD = 6.5 months). Patient characteristics such as demographics and diagnosis were not significantly related to their survival time. There were no significant differences in survival time between patients receiving hospice at home (n = 22) and those receiving institutional hospice (n = 25).
Predictors of Survival Time tients in the second cohort and are shown below.
FAST Scores
FAST scores were the strongest predictor, ( Y = -.66, P < .01, n = 17). However, as discussed in a later section, many patients could not be scored.
Performance Ratings
Mobility impairments were highly correlated with survival times ( Y = -35, P < .001, n = 32), as were ratings of Appetite (Y = -.47, P < .01, n = 29). Nourishment was not significant (Y = -.24, P = .19, n = 32). Functional impairment, as indicated by a total score on Activities of Daily Living, was also a strong predictor of survival time, (Y = 5 1 , P < .01, n = 32).
Medical Complications
It was not possible to examine the role of specific comorbidities, because most patients had more than one medical complication. However, the more complications the patients had, the shorter their survival time (Y = -41, P < .05, n = 29).
Multivariate Analysis
Multivariate analysis using multiple regression was conducted next to examine the relation between survival time and those predictors that were significant using univariate analysis. FAST scores were excluded from this analysis because only 17 patients could be assessed (as discussed below). Only performance ratings of mobility remained significant in this analysis (F = 12.05, P < .01) and accounted for 28% of the variance in survival time (Adjusted R2 = 28.3, n' = 29 to 32).
Predictors of survival time were examined only for paProblems in Using the FAST Because of time constraints, hospice staff were often unable to score the FAST, resulting in missing data for 19% of the second cohort (n = 7). A more important issue was that the assumption of an ordinal pattern of deterioration in the FAST proved to be inaccurate for 12 (41 %) of the 29 patients for whom this data was available (see Appendix). As a result, patients were next grouped in one of the following three categories:
Patient Has Not Deteriorated to the Point of Reaching Stage
Seven C or Greater (n = 5)
Because the enrollment criteria suggested that patients have impairments in most or all ADLs, relatively few patients were in this group. One of these patients was at Stage Six E at intake, and the others were at Stage Seven A (n = 2) or Stage Seven B (n = 2). Although their verbal ability varied, the ability of these patients to walk was not impaired. The most striking finding was that all patients who could be scored in an ordinal fashion and who had not reached Stage Seven C were still surviving, with a mean survival time of 18.1 months
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(SD = 7.1 months). All of these patients survived for more than 6 months.
Patient Has Deteriorated to Stage Seven C or Greater (n = 12)
The distinguishing characteristic of Stage Seven C is that, in addition to being limited to one word a day, ambulation is impaired. Mean survival time was 3.2 months (SD = 3.8 months), and 11 of 12 patients (92%) were deceased. Two patients (17%) survived longer than 6 months.
Patient Did Not Follow an Ordinal Progression (n = 12)
The major difficulty in scoring the FAST in this group was their intelligible vocabulary had not decreased to one word a day. They could not, therefore, be coded as having progressed through Stage 7B, yet they had mobility impairments that would otherwise be characteristic of Stage 7C. Because their verbal impairment had not decreased to Stage Seven B (single woraday), their disease progression did not follow the sequence necessary for their assessment on the FAST. Within this group, the mean survival time was 8.6 months (SD = 7 months); 11 of 12 patients (92%) were deceased but seven (58%) survived for more than 6 months.
Survival times among these three groups differed significantly, P < .001 (ANOVA, F = 11.52). All pairwise comparisons were also significant (Tukey-B test, P < .05).
Palliative Care Plan When both FAST status and care plans were examined jointly, each had an effect on survival times ( Table 3) . Patients whose care plans called for the use of medication for acute illness had longer survival times than those without this provision, P < .01. There were no significant interactions.
Limitation
The small sample size limited multivariate analysis to the detection of large effect sizes. However, a large effect could be expected to have clinical significance in decision-making. Further research with a larger sample would be useful in Table 3 examining such issues as the relative importance of specific medical complications.
DISCUSSION
Our proposed hospice enrollment criteria identified a group of dementia patients with a median survival time of 4 months; 38% survived past 6 months. These results are similar to the median survival of 2.5 months, with 35% living past 6 months, reported in a national study of Medicare hospice beneficiaries with a primary diagnosis of dementia." Although all the patients in our study were severely demented, there were still gradations of disability that our subsequent analysis shows are related to differing survival patterns. Patients who can be scored on the FAST and who have not reached Stage Seven C are unlikely to die within 6 months. These patients do not appear to fit current requirements for eligibility for hospice. In contrast, patients who can be scored on the FAST and who have reached Stage Seven C appear to be good candidates for hospice as most of those enrolled in the study died (11 of 12), with a mean survival time of 3.2 months, and only two patients (17%) survived more than 6 months.
It is the patient whose disease progression was not ordinal who poses problems in using the FAST as an enrollment criterion. Problems in the assumption of an ordinal deterioration in dementia have been identified in our previous research using a sample from an Alzheimer's Disease Registry. 20 The use of Stage Seven C as a cutoff is problematic because the lack of ordinality precluded using this measure for almost half of the patients in the second cohort. The non-ordinal patients had impaired mobility consistent with Stage Seven C but less severely impaired language function (i.e., greater than one word a day).
It is not clear whether the Medicare policy for a 6-month prognosis refers to a median survival time, a mean survival time, or that 75%, or 85%, or 95% should be deceased at that point. 21 Obviously, the more stringent the interpretation, the more patients would lose access to hospice services. This issue is of particular importance for those severely demented patients whose disease progression did not follow an ordinal pattern. One possible way of dealing with these patients would be to assume that further deterioration, for instance, in their scant remaining language ability, might occur, and that hospice admission could be delayed until this deterioration took place. They would then be at Stage Seven C, regardless of initial ordinality. Inasmuch as our study did not measure deterioration on the FAST over time, we cannot analyze this possibility directly. Because the FAST was only available at hospice enrollment, we have instead examined how long these patients survived in hospice in order to estimate what proportion would have survived if hospice admission were delayed for varying time periods in order to reevaluate their deterioration. Within 1 month of hospice enrollment one such patient died (8Yo of this group). By the third month of hospice care, another three patients died (25%); one more died in the fourth month for a total of five or 42% within 4 months of hospice enrollment. If strict adherence to Stage Seven C of the FAST is required before enrollment, then frequent re-evaluation of non-ordinal patients would be necessary or many of these patients would have died without benefit of hospice.
This analysis may underestimate the impact of delay on enrollment because it ignores the effect of treatment on survival. For the non-ordinal group, even though all were enrolled in hospice, there was a 3-fold difference in survival between those who received (14.9 months) and those who did not receive (5.2 months) medications for acute illness. This finding is similar to the life-prolonging effect of treating fever observed by Volicer and his colleagues in those with less severe disability.12 This effect of treatment suggests that non-ordinal end stage dementia patients, with impaired mobility and better preserved language, might be suitable for hospice if their palliative care plans were conservative and not suitable if more life-prolonging care was anticipated.
In summary, our findings and this discussion would support the use of the NHO guidelines for enrolling dementia patients. Those individuals who clearly meet the guidelines are appropriate for the Medicare hospice benefit, whereas those who clearly do not meet the guidelines are not appropriate. Thus the NHO guidelines -when applicable -offer a very useful set of criteria for hospice enrollment with eligibility for Medicare reimbursement. The problem we have identified and tried to address is that of individuals who cannot be categorized on the FAST because their progression is not ordinal.
It is possible that with additional iterations, some modification of our criteria and/or procedures for dealing with individuals who do not progress ordinally on the FAST might be shown to define a group of end stage dementia patients who fulfill the requirement of dying in 6 months. However, one could question this effort and consider alternative approaches. When the admission guideline concerning a 6-months survival time was initially adopted for the Medicare hospice benefit, most hospice patients were dying of cancer. The use of this guideline for the new groups of patients that hospices have begun to serve, notably dementia patients and AIDS patients, may not be appropriate. Although hospice programs have expanded greatly since their inception, only about 15% of terminal patients receive hospice services annually.22 Alternatives to the Medicare hospice benefit have been proposed for patients who are not dying of cancer, but at this point hospice care is the only major program organized specifically for the needs of dying pat i e n t~.~~ In order to make this important service more accessible, less rigorous admissions criteria have been suggested for AIDS patients, for example, a limited prognosis and a need for skilled nursing.24 Similar flexibility may be needed for end-stage dementia patients.
